BioNexus Gene Lab Corp. has completed an IPO in the amount of $5 million.
Security Name: Common Stock
Security Type: Common Stock
Securities Offered: 1,250,000
PriceRange: $4
Discount Per Security: $0.32
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.5801 USD | -0.03% | -2.49% | +9.45% |
04-16 | BioNexus Gene Lab Corp. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
02-29 | BioNexus Gene Lab Corp. Provides Information to Shareholders | CI |
1st Jan change | Capi. | |
---|---|---|
+9.45% | 10.25M | |
+26.37% | 48.16B | |
-1.01% | 41.73B | |
+46.00% | 41.03B | |
-5.31% | 28.77B | |
+9.34% | 25.59B | |
-21.69% | 18.96B | |
+6.23% | 12.92B | |
+26.99% | 12.03B | |
-3.38% | 11.77B |